[New drugs in oncology: benefits, risks and challenges]
- PMID: 23921801
- DOI: 10.1159/000352000
[New drugs in oncology: benefits, risks and challenges]
Similar articles
-
[Targeted therapy: old and new possibilities].Onkologie. 2013;36 Suppl 5:2-11. doi: 10.1159/000351997. Epub 2013 Jul 1. Onkologie. 2013. PMID: 23921800 German. No abstract available.
-
[Adequate supportive treatment in therapeutic use of "biologicals" for GI tumours in oncosurgery--what does the surgeon need to know?].Zentralbl Chir. 2013 Apr;138(2):204-9. doi: 10.1055/s-0032-1327969. Epub 2013 Apr 5. Zentralbl Chir. 2013. PMID: 23564552 Review. German.
-
[Modern anti-cancer therapy: current state and future developments].Dtsch Med Wochenschr. 2014 Oct;139(41):2067. doi: 10.1055/s-0034-1387350. Epub 2014 Sep 30. Dtsch Med Wochenschr. 2014. PMID: 25268204 German. No abstract available.
-
Combining biological agents and chemotherapy in the treatment of cholangiocarcinoma.Expert Rev Anticancer Ther. 2011 Apr;11(4):589-600. doi: 10.1586/era.11.17. Expert Rev Anticancer Ther. 2011. PMID: 21504326 Review.
-
Skin care for cancer patients.Clin Adv Hematol Oncol. 2012 Nov;10(11):748-50. Clin Adv Hematol Oncol. 2012. PMID: 23271263 No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources